Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSB-001 in Subjects With Corneal Scars
NCT06257355Phase 1Recruiting
- Sponsor
- Claris Bio
- Start
- Feb 2024
- Primary completion
- Jun 2027
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 1, open-label trial of dHGF in Corneal scar (2 arms), sponsored by Claris Bio. Primary endpoints: Safety as Assessed by Adverse Event Reporting, Safety as Assessed by Slit-lamp Biomicroscopy and 1 more. Started Feb 2024; status: recruiting.
02
Drugs
dHGF
03
Conditions
Corneal scar
Beyond the preview
Go deeper on NCT06257355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06257355.